No nod for Bharat Bio's Covaxin yet, WHO seeks 'additional clarifications'

The technical advisory group will now meet on November 3 for a final assessment.

Bharat Biotech, Covaxin

Hyderabad-based Bharat Biotech, which has developed Covaxin, had submitted EOI (Expression of Interest) to the WHO on April 19 for the vaccine's Emergency Use Listing (EUL)

United Nations/Geneva
The World Health Organisation's technical advisory group on Tuesday sought "additional clarifications" from Bharat Biotech for its Covid-19 vaccine Covaxin to conduct a final “risk-benefit assessment” for Emergency Use Listing

Also Read

Long wait: Vaccine makers queue up for WHO approval, shows data

WHO technical advisory group to take call on Covaxin EUL next week

Booster dose: Bharat Biotech's nasal vaccine may be used with Covaxin

Bharat Biotech likely to start manufacturing Covaxin at Pune plant soon

Covaxin 77.8% effective against symptomatic Covid-19: Bharat Biotech

Over 1.03 billion vaccine doses administered in India so far, says govt

Delhi records 41 Covid-19 cases, zero death; positivity rate at 0.08%

Review of Covaxin underway, expect a recommendation within 24 hours: WHO

Centre asks West Bengal to immediately undertake a review of Covid cases

AAR says no GST exemption for tourist vehicles carrying Covid patients

First Published: Oct 26 2021 | 11:48 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to